Answers are grounded in this paper and cite their sources.
The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway contributes to tumor immune evasion and represents an emerging topic in canine oncology. In canine urothelial carcinoma (UC), PD-L1 immunohistochemical evaluation may be challenging because of staining heterogeneity, and only membranous labeling is considered specific. This study assessed the feasibility of a computer-aided image analysis workflow incorporating supervised classification tools for PD-L1 scoring on whole-slide images of canine UC. Immunohistochemistry was performed using a validated anti-PD-L1 antibody. Digital slides were analyzed with QuPath software using object- and pixel-based classifiers to identify PD-L1-positive tumor and immune cells and to calculate the combined positive score (CPS). Ten of 48 tumors (21%) showed PD-L1 expression. CPS values obtained by computer-aided analysis correlated with manual counts. Interobserver agreement for manual CPS assessment among multiple pathologists was good (intraclass correlation coefficient = 0.795). These results indicate that computer-aided whole-slide analysis is a feasible supportive approach for PD-L1 scoring in canine UC under pathologist supervision.
No takes yet. Share an insight, caveat, or question.
Muscatello et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: